Concepedia

Protected Drug Classes

Protected Drug Classes is a regulatory category in medication coverage policy that comprises pharmacological classes of drugs requiring special access safeguards and typically mandating coverage of all or substantially all agents within the class to ensure therapeutic access for vulnerable populations.

6

Publications

110

Citations

23

Authors

16

Institutions

Publications per year

2017–2026

2

Parents

Publications

6

Prescribing restrictions – a necessary strategy among some European countries to enhance future prescribing efficiency?

Brian Godman, Rickard E. Malmström, Marion Bennie et al. · Reviews in Health Care · 2011 · 31 citations · Full text

, , +14

Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval

Daniel L Shaw, Sanket S. Dhruva, Joseph S. Ross · Journal of Managed Care & Specialty Pharmacy · 2018 · 25 citations · Full text

, , +16

APA Opposes Trump Administration Plan Targeting Psychiatric Drugs in Medicare

Linda M. Richmond · Psychiatric News · 2019 · 16 citations

, , +17

Medicare Part D and Nursing Home Residents

David G. Stevenson, Haiden A. Huskamp, Nancy L. Keating et al. · Journal of the American Geriatrics Society · 2007 · 14 citations

, , +16

Impacts of Generic Competition and Benefit Management Practices on Spending for Prescription Drugs: Evidence from Medicare’s Part D Benefit

Steven H. Sheingold, Nguyen Nguyen · Medicare & Medicaid Research Review · 2014 · 12 citations · Full text

, , +17

1–5 of 6

Authors

23

  1. DL
    Daniel L Shaw

    University of Minnesota, United States

    1 publications · 25 citations

    1

    h-index

  2. LM
    Lisa Mucha

    Takeda (United States), United States

    1 publications · 12 citations

    1

    h-index

  3. NL
    Nancy L. Keating

    Harvard University, United States

    1 publications · 14 citations

    1

    h-index

  4. SC
    Stephen Campbell

    University of Manchester, United Kingdom

    1 publications · 31 citations

    1

    h-index

  5. LL
    Lars L. Gustafsson

    Karolinska Institutet, Sweden

    1 publications · 31 citations

    1

    h-index

1–5 of 23

Institutions

16

  1. Brigham and Women's Hospital

    Boston, United States

    1 h-index

    4 publications

    56 citations

  2. Karolinska Institutet

    Stockholm, Sweden

    1 h-index

    3 publications

    93 citations

  3. University of Strathclyde

    Glasgow, United Kingdom

    1 h-index

    1 publications

    31 citations

  4. Technicolor (France)

    Paris, France

    1 h-index

    1 publications

    12 citations

  5. Norwegian Institute of Public Health

    Oslo, Norway

    1 h-index

    1 publications

    31 citations

  6. Karolinska University Hospital

    Stockholm, Sweden

    1 h-index

    3 publications

    93 citations

  7. Heidelberg University

    Heidelberg, Germany

    1 h-index

    1 publications

    31 citations

  8. Pfizer (United States)

    New York, United States

    1 h-index

    2 publications

    24 citations

1–8 of 16

Venues

  1. Journal of Managed Care & Specialty Pharmacy

    JMCP · 1 publications · 25 citations

    1

    h-index

  2. Journal of the American Geriatrics Society

    1 publications · 14 citations

    1

    h-index

  3. PharmacoEconomics

    1 publications · 12 citations

    1

    h-index

  4. Reviews in Health Care

    1 publications · 31 citations

    1

    h-index

  5. Medicare & Medicaid Research Review

    MMRR · 1 publications · 12 citations

    1

    h-index

1–5